Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients

被引：0
|
作者：
Daphne SC Lee
Sook-Yee Yoon
Lai Meng Looi
Peter Kang
In Nee Kang
Kavitta Sivanandan
Hany Ariffin
Meow Keong Thong
Kin Fah Chin
Nur Aishah Mohd Taib
Cheng-Har Yip
Soo-Hwang Teo
机构：
[1] Sime Darby Medical Centre,Cancer Research Initiatives Foundation
[2] University Malaya Medical Centre,Department of Pathology
[3] University Malaya,Department of Paediatrics
[4] University Malaya Cancer Research Institute,Department of Surgery
[5] University Malaya Medical Centre,undefined
[6] University Malaya,undefined
[7] University Malaya Medical Centre,undefined
[8] University Malaya,undefined
[9] University Malaya Medical Centre,undefined
[10] University Malaya,undefined
来源：
Breast Cancer Research | / 14卷
关键词：
Breast Cancer; TP53 Mutation; Contralateral Breast Cancer; Germline TP53 Mutation; TP53 Mutation Carrier;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients
    Lee, Daphne S. C.
    Yoon, Sook-Yee
    Looi, Lai Meng
    Kang, Peter
    Kang, In Nee
    Sivanandan, Kavitta
    Ariffin, Hany
    Thong, Meow Keong
    Chin, Kin Fah
    Taib, Nur Aishah Mohd
    Yip, Cheng-Har
    Teo, Soo-Hwang
    BREAST CANCER RESEARCH, 2012, 14 (02):
  • [2] BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives
    Lalloo, F
    Varley, J
    Moran, A
    Ellis, D
    O'Dair, L
    Pharoah, P
    Antoniou, A
    Hartley, R
    Shenton, A
    Seal, S
    Bulman, B
    Howell, A
    Evans, DGR
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (08) : 1143 - 1150
  • [3] Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours
    Ramus, SJ
    Bobrow, LG
    Pharoah, PDP
    Finnigan, DS
    Fishman, A
    Altaras, M
    Harrington, PA
    Gayther, SA
    Ponder, BAJ
    Friedman, LS
    GENES CHROMOSOMES & CANCER, 1999, 25 (02): : 91 - 96
  • [4] BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma
    Christian Monnerat
    Agnès Chompret
    Caroline Kannengiesser
    Marie-Françoise Avril
    Nicolas Janin
    Alain Spatz
    Jean-Marc Guinebretière
    Catalin Marian
    Michel Barrois
    Françoise Boitier
    Gilbert M. Lenoir
    Brigitte Bressac-de Paillerets
    Familial Cancer, 2007, 6 : 453 - 461
  • [5] BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma
    Monnerat, Christian
    Chompret, Agnes
    Kannengiesser, Caroline
    Avril, Marie-Francois
    Janin, Nicolas
    Spatz, Alain
    Guinebretiere, Jean-Marc
    Marian, Catalin
    Barrois, Michel
    Boitier, Francois
    Lenoir, Gilbert M.
    Paillerets, Brigitte Bressac-de
    FAMILIAL CANCER, 2007, 6 (04) : 453 - 461
  • [6] Comprehensive Analysis of BRCA1, BRCA2 and TP53 Germline Mutation and Tumor Characterization: A Portrait of Early-Onset Breast Cancer in Brazil
    Carraro, Dirce Maria
    Azevedo Koike Folgueira, Maria Aparecida
    Garcia Lisboa, Bianca Cristina
    Ribeiro Olivieri, Eloisa Helena
    Vitorino Krepischi, Ana Cristina
    de Carvalho, Alex Fiorini
    de Carvalho Mota, Louise Danielle
    Puga, Renato David
    Maciel, Maria do Socorro
    Depieri Michelli, Rodrigo Augusto
    de Lyra, Eduardo Carneiro
    Giorgi Grosso, Stana Helena
    Soares, Fernando Augusto
    de Souza Waddington Achatz, Maria Isabel Alves
    Brentani, Helena
    Moreira-Filho, Carlos Alberto
    Brentani, Maria Mitzi
    PLOS ONE, 2013, 8 (03):
  • [7] Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative french canadian breast cancer families
    Arcand, Suzanna L.
    Maugard, Christine M.
    Ghadirian, Parviz
    Robidoux, Andre
    Perret, Chantal
    Zhang, Phil
    Fafard, Eve
    Mes-Masson, Anne-Marie
    Foulkes, William D.
    Provencher, Diane
    Narod, Steven A.
    Tonin, Patricia N.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 108 (03) : 399 - 408
  • [8] Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families
    Suzanna L. Arcand
    Christine M. Maugard
    Parviz Ghadirian
    André Robidoux
    Chantal Perret
    Phil Zhang
    Eve Fafard
    Anne-Marie Mes-Masson
    William D. Foulkes
    Diane Provencher
    Steven A. Narod
    Patricia N. Tonin
    Breast Cancer Research and Treatment, 2008, 108 : 399 - 408
  • [9] Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutations
    Ghezelayagh, Talayeh S.
    Pennington, Kathryn P.
    Norquist, Barbara M.
    Khasnavis, Nithisha
    Radke, Marc R.
    Kilgore, Mark R.
    Garcia, Rochelle L.
    Lee, Ming
    Katz, Ronit
    Leslie, Kimberly K.
    Risques, Rosa Ana
    Swisher, Elizabeth M.
    GYNECOLOGIC ONCOLOGY, 2021, 160 (03) : 786 - 792
  • [10] Alterations in BRCA1, BRCA2, TP53 and ATM genes in sporadic breast tumours
    Prokopcova, J.
    Soukupova, J.
    Ticha, I.
    Janatova, M.
    Sevcik, J.
    Kleibl, Z.
    Kleiblova, P.
    Pohlreich, P.
    EJC SUPPLEMENTS, 2010, 8 (05): : 203 - 203
12345